Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Statistics

Total Valuation

CRDF has a market cap or net worth of $130.90 million. The enterprise value is $73.39 million.

Market Cap	130.90M
Enterprise Value	73.39M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

CRDF has 51.13 million shares outstanding. The number of shares has increased by 1.40% in one year.

Current Share Class	51.13M
Shares Outstanding	51.13M
Shares Change (YoY)	+1.40%
Shares Change (QoQ)	+4.55%
Owned by Insiders (%)	1.89%
Owned by Institutions (%)	25.24%
Float	47.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	166.46
Forward PS	693.07
PB Ratio	2.50
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	106.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.03.

Current Ratio	4.74
Quick Ratio	4.65
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.57% and return on invested capital (ROIC) is -44.22%.

Return on Equity (ROE)	-67.57%
Return on Assets (ROA)	-38.33%
Return on Capital (ROIC)	-44.22%
Revenue Per Employee	$21,500
Profits Per Employee	-$1.34M
Employee Count	32
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +118.10% in the last 52 weeks. The beta is 1.93, so CRDF's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	+118.10%
50-Day Moving Average	2.84
200-Day Moving Average	3.10
Relative Strength Index (RSI)	40.61
Average Volume (20 Days)	1,084,404

Short Selling Information

The latest short interest is 8.07 million, so 15.78% of the outstanding shares have been sold short.

Short Interest	8.07M
Short Previous Month	7.32M
Short % of Shares Out	15.78%
Short % of Float	16.89%
Short Ratio (days to cover)	11.51

Income Statement

In the last 12 months, CRDF had revenue of $688,000 and -$43.01 million in losses. Loss per share was -$0.95.

Revenue	688,000
Gross Profit	-34.22M
Operating Income	-46.41M
Pretax Income	-40.86M
Net Income	-43.01M
EBITDA	-46.00M
EBIT	-46.41M
Loss Per Share	-$0.95

Balance Sheet

The company has $57.67 million in cash and $1.69 million in debt, giving a net cash position of $55.98 million or $1.09 per share.

Cash & Cash Equivalents	57.67M
Total Debt	1.69M
Net Cash	55.98M
Net Cash Per Share	$1.09
Equity (Book Value)	49.39M
Book Value Per Share	1.01
Working Capital	46.81M

Cash Flow

In the last 12 months, operating cash flow was -$34.57 million and capital expenditures -$88,000, giving a free cash flow of -$34.65 million.

Operating Cash Flow	-34.57M
Capital Expenditures	-88,000
Free Cash Flow	-34.65M
FCF Per Share	-$0.68

Margins

Gross Margin	n/a
Operating Margin	-6,745.78%
Pretax Margin	-6,247.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,882.56%

Dividends & Yields

CRDF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.40%
Shareholder Yield	-1.40%
Earnings Yield	-33.24%
FCF Yield	-26.79%

Analyst Forecast

The average price target for CRDF is $9.33, which is 264.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.33
Price Target Difference	264.45%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	-26.88%
EPS Growth Forecast (5Y)	19.80%

Stock Splits

The last stock split was on February 20, 2019. It was a reverse split with a ratio of 0.1666666:1.

Last Split Date	Feb 20, 2019
Split Type	Reverse
Split Ratio	0.1666666:1

Scores

CRDF has an Altman Z-Score of -4.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.83
Piotroski F-Score	3